We are live on ! Find out more
SGYPW

Synergy Pharmaceuticals, Inc. - Warrants
SGYPW

Delisted

SGYPW was delisted on the 6th of December, 2016.

Back to rankings

5 hedge funds and large institutions have $1.2M invested in Synergy Pharmaceuticals, Inc. - Warrants in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 4 → 5 (+1)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

36% less capital invested

Capital invested by funds: $1.89M → $1.2M (-$684K)

53% less call options, than puts

Call options by funds: $1.38M | Put options by funds: $2.96M

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
–
Calls
$1.38M
Puts
$2.96M
Net Calls
-$1.58M
Net Calls Change
-$1M

Top Buyers

Rank Fund Capital Flow
1
Twin Tree Management
Twin Tree Management
Texas
+$8.82K
2
UBS Group
UBS Group
Switzerland
+$4.06K
3
TRCT
Tower Research Capital (TRC)
New York
+$2.3K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$189K
2
CI
Cowen Inc
New York
-$141K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$1.11M -$189K -108,021 -27%
Twin Tree Management
2
Twin Tree Management
Texas
$78K +$8.82K +5,029 +34%
UBS Group
3
UBS Group
Switzerland
$9K +$4.06K +2,313 New
TRCT
4
Tower Research Capital (TRC)
New York
$5K +$2.3K +1,309 +2,424%
CI
5
Cowen Inc
New York
– -$141K -80,500 -40%

SGYPW Hedge Fund Activity: Q2 2015 in Review

5 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q2 2015, worth a combined $1.2M — down 36% from $1.89M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new SGYPW positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Twin Tree Management, adding an estimated $8.82K. The largest seller was Sabby Management, cutting an estimated $189K.

  • 5 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q2 2015, up from 4 in Q1 2015.
  • Funds reported $1.2M of Synergy Pharmaceuticals, Inc. - Warrants stock for Q2 2015, down 36% quarter-over-quarter.
  • 1 fund opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q2 2015 and 0 closed out, a net change of +1 holder.
  • The largest Synergy Pharmaceuticals, Inc. - Warrants buyer in Q2 2015 was Twin Tree Management, an estimated $8.82K added.
  • The largest Synergy Pharmaceuticals, Inc. - Warrants seller in Q2 2015 was Sabby Management, an estimated $189K sold.

Based on aggregated 13F filings for Q2 2015.